Thanh Thao Nguyen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Thanh Thao Nguyen has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Sohsuke Yamada
Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Ishikawa, JPN
3 shared publications- Sohsuke Yamada
Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan
3 shared publications - Akihiro Shioya
Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Uchinada, Japan
2 shared publications - Dung Anh Vu
Department of Joint Surgery 103 Military Hospital Hanoi Vietnam
2 shared publications - Katsuhito Miyazawa
Department of Urology, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan
2 shared publications Motona Kumagai
Department of Pathology, Kanazawa Medical University Hospital, Ishikawa, JPN
2 shared publications
Latest Publications
- Open Access
- 13 October 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (10) , 1488
Glyceraldehyde May Induce the Generation of High-Molecular-Weight Species of HSP90β and Autophagy-Related Proteins and Alter Protein Levels in Human Renal Epithelial Cells
Kidney disease (KD) is a major health problem, and metabolic disorders contribute to diabetic nephropathy and chronic kidney disease, in which renal epithelial cell dysfunction plays an important role. Intracellular advanced glycation end-products (AGEs) may contribute to KD progression by disrupting cellular homeostasis; however, the underlying mechanisms remain unclear. Therefore, we aimed to investigate the effects of glyceraldehyde (GA) on molecular chaperone- and autophagy-related proteins in human renal epithelial cells (HK-2), with particular attention to AGE-related processes. Administration of high-fructose corn syrup to healthy Wistar rats increased argpyrimidine immunoreactivity in the renal tubular epithelial cells, compared with that in controls, suggesting enhanced accumulation of this GA-related AGE in vivo. In HK-2 cells, GA treatment caused concentration-dependent reductions in NADPH and ATP levels, accompanied by morphological changes. High molecular weight (HMW) immunoreactive species of HSP90β, Beclin-1, and ATG7 appeared following GA treatment. GA at 1.5 mM increased LC3-I, LC3-II, and p62 levels, whereas treatment with 2 mM GA attenuated these increases. Aminoguanidine, an inhibitor of AGE formation, attenuated these GA-induced alterations. Overall, GA may induce the generation of HMW species of HSP90β and autophagy-related proteins and may contribute to altered cellular homeostasis, with AGE-related processes potentially contributing to these effects.
- 13 October 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (10) , 1488
Open AccessGlyceraldehyde May Induce the Generation of High-Molecular-Weight Species of HSP90β and Autophagy-Related Proteins and Alter Protein Levels in Human Renal Epithelial Cells
Kidney disease (KD) is a major health problem, and metabolic disorders contribute to diabetic nephropathy and chronic kidney disease, in which renal epithelial cell dysfunction plays an important role. Intracellular advanced glycation end-products (AGEs) may contribute to KD progression by disrupting cellular homeostasis; however, the underlying mechanisms remain unclear. Therefore, we aimed to investigate the effects of glyceraldehyde (GA) on molecular chaperone- and autophagy-related proteins in human renal epithelial cells (HK-2), with particular attention to AGE-related processes. Administration of high-fructose corn syrup to healthy Wistar rats increased argpyrimidine immunoreactivity in the renal tubular epithelial cells, compared with that in controls, suggesting enhanced accumulation of this GA-related AGE in vivo. In HK-2 cells, GA treatment caused concentration-dependent reductions in NADPH and ATP levels, accompanied by morphological changes. High molecular weight (HMW) immunoreactive species of HSP90β, Beclin-1, and ATG7 appeared following GA treatment. GA at 1.5 mM increased LC3-I, LC3-II, and p62 levels, whereas treatment with 2 mM GA attenuated these increases. Aminoguanidine, an inhibitor of AGE formation, attenuated these GA-induced alterations. Overall, GA may induce the generation of HMW species of HSP90β and autophagy-related proteins and may contribute to altered cellular homeostasis, with AGE-related processes potentially contributing to these effects.
- 6 July 2026
- Published by Wiley in Diagnostic Cytopathology
- Vol. 54 (10) , 764-772
Clinical and Cytopathological Significance of Intracytoplasmic Lumina and Immunohistochemical Mucin Expression in Non‐Muscle‐Invasive Urothelial Carcinoma of the Bladder
Background: Intracytoplasmic lumina (ICL) are mucin‐containing structures identified in histological and cytological specimens of urothelial carcinoma and are associated with high‐grade tumors and poor prognosis. However, their biological significance remains unclear. This study investigated mucin expression in ICL and its association with clinical, cytopathological, and prognostic features in non‐muscle‐invasive urothelial carcinoma of the bladder. Methods: A total of 105 cases of non‐muscle‐invasive urothelial carcinoma of the bladder diagnosed were examined. Immunohistochemical staining for MUC1, MUC2, MUC4, MUC5AC, and MUC6 was performed in 47 cases in which ICL were identified histologically, and the staining patterns of ICL and tumor cells were evaluated. The presence of ICL in urine cytology specimens was assessed, and its associations with tumor‐specific survival and recurrence were analyzed statistically. Results: ICL were identified in 47 cases histologically and in 33 cases cytologically. ICL‐positive tumors were more frequently observed in high‐grade histology and were more often diagnosed as malignant or suspicious for malignancy in urine cytology. Immunohistochemically, MUC1 was the most frequently expressed mucin, with localization along the microvilli of the ICL lumen and within luminal mucin. Increased expression of MUC4 and MUC5AC showed a trend toward decreased survival. Conclusion: ICL in non‐muscle‐invasive urothelial carcinoma is more frequently observed in high‐grade tumors and shows characteristic mucin expression patterns, particularly MUC1 localization within ICL structures. Increased expression of MUC4 and MUC5AC may be associated with unfavorable clinical outcomes. These findings suggest that combined evaluation of ICL and mucin expression may provide additional prognostic information in urothelial carcinoma.
- 6 July 2026
- Published by Wiley in Diagnostic Cytopathology
- Vol. 54 (10) , 764-772
Clinical and Cytopathological Significance of Intracytoplasmic Lumina and Immunohistochemical Mucin Expression in Non‐Muscle‐Invasive Urothelial Carcinoma of the Bladder
Background: Intracytoplasmic lumina (ICL) are mucin‐containing structures identified in histological and cytological specimens of urothelial carcinoma and are associated with high‐grade tumors and poor prognosis. However, their biological significance remains unclear. This study investigated mucin expression in ICL and its association with clinical, cytopathological, and prognostic features in non‐muscle‐invasive urothelial carcinoma of the bladder. Methods: A total of 105 cases of non‐muscle‐invasive urothelial carcinoma of the bladder diagnosed were examined. Immunohistochemical staining for MUC1, MUC2, MUC4, MUC5AC, and MUC6 was performed in 47 cases in which ICL were identified histologically, and the staining patterns of ICL and tumor cells were evaluated. The presence of ICL in urine cytology specimens was assessed, and its associations with tumor‐specific survival and recurrence were analyzed statistically. Results: ICL were identified in 47 cases histologically and in 33 cases cytologically. ICL‐positive tumors were more frequently observed in high‐grade histology and were more often diagnosed as malignant or suspicious for malignancy in urine cytology. Immunohistochemically, MUC1 was the most frequently expressed mucin, with localization along the microvilli of the ICL lumen and within luminal mucin. Increased expression of MUC4 and MUC5AC showed a trend toward decreased survival. Conclusion: ICL in non‐muscle‐invasive urothelial carcinoma is more frequently observed in high‐grade tumors and shows characteristic mucin expression patterns, particularly MUC1 localization within ICL structures. Increased expression of MUC4 and MUC5AC may be associated with unfavorable clinical outcomes. These findings suggest that combined evaluation of ICL and mucin expression may provide additional prognostic information in urothelial carcinoma.
- Open Access
- 9 February 2026
- Published by Springer Nature in Cureus
- Vol. 18 (2)
Thymic Atypical Carcinoid Mimicking Recurrent Type A Thymoma on Frozen Section: A Diagnostic Pitfall Resolved by Intraoperative Imprint Cytology
Thymic neuroendocrine neoplasms (tNENs) are rare anterior mediastinal tumors with aggressive behavior and can be misdiagnosed as type A thymoma on small biopsies or intraoperative frozen sections, although accurate distinction is critical for prognosis and management. Type A thymoma, while generally considered a low-grade malignant tumor with a favorable prognosis, comprises a small subset that exhibits aggressive features and develops distant metastases after surgical resection; these tumors are classified as atypical type A thymomas. A 72-year-old woman had a history of resected atypical type A thymoma two years earlier. Surveillance computed tomography revealed a 15-mm mediastinal nodule located anterior to the superior vena cava with intense fluorodeoxyglucose uptake on positron emission tomography-computed tomography. Frozen sections showed a proliferation of small- to medium-sized polygonal and short spindle cells arranged in solid nests and trabeculae without a lymphocyte-rich background, and were interpreted as recurrent atypical type A thymoma. In contrast, imprint cytology demonstrated monomorphic small- to medium-sized tumor cells with round to oval nuclei, finely granular “salt-and-pepper” chromatin, inconspicuous nucleoli, loose cohesion, and scattered rosette-like structures, strongly suggesting a tNEN. Permanent sections revealed nests, trabeculae, and rosettes of small- to medium-sized polygonal cells with granular chromatin and approximately four mitoses per 10 high-power fields, without large confluent necrosis. Immunohistochemistry showed diffuse positivity for CD56, chromogranin A, synaptophysin, and insulinoma-associated protein 1; a Ki-67 index of about 20%; negativity for CD5, CD117 (c-KIT), p63 (TP63), CK5/6, and CD20; and the absence of TdT/CD99-positive immature T cells, supporting a diagnosis of thymic atypical carcinoid. This case highlights the complementary value of imprint cytology and an appropriate immunohistochemical panel, in addition to frozen sections, in avoiding misclassification of tNENs as type A thymoma.
- 9 February 2026
- Published by Springer Nature in Cureus
- Vol. 18 (2)
Open AccessThymic Atypical Carcinoid Mimicking Recurrent Type A Thymoma on Frozen Section: A Diagnostic Pitfall Resolved by Intraoperative Imprint Cytology
Thymic neuroendocrine neoplasms (tNENs) are rare anterior mediastinal tumors with aggressive behavior and can be misdiagnosed as type A thymoma on small biopsies or intraoperative frozen sections, although accurate distinction is critical for prognosis and management. Type A thymoma, while generally considered a low-grade malignant tumor with a favorable prognosis, comprises a small subset that exhibits aggressive features and develops distant metastases after surgical resection; these tumors are classified as atypical type A thymomas. A 72-year-old woman had a history of resected atypical type A thymoma two years earlier. Surveillance computed tomography revealed a 15-mm mediastinal nodule located anterior to the superior vena cava with intense fluorodeoxyglucose uptake on positron emission tomography-computed tomography. Frozen sections showed a proliferation of small- to medium-sized polygonal and short spindle cells arranged in solid nests and trabeculae without a lymphocyte-rich background, and were interpreted as recurrent atypical type A thymoma. In contrast, imprint cytology demonstrated monomorphic small- to medium-sized tumor cells with round to oval nuclei, finely granular “salt-and-pepper” chromatin, inconspicuous nucleoli, loose cohesion, and scattered rosette-like structures, strongly suggesting a tNEN. Permanent sections revealed nests, trabeculae, and rosettes of small- to medium-sized polygonal cells with granular chromatin and approximately four mitoses per 10 high-power fields, without large confluent necrosis. Immunohistochemistry showed diffuse positivity for CD56, chromogranin A, synaptophysin, and insulinoma-associated protein 1; a Ki-67 index of about 20%; negativity for CD5, CD117 (c-KIT), p63 (TP63), CK5/6, and CD20; and the absence of TdT/CD99-positive immature T cells, supporting a diagnosis of thymic atypical carcinoid. This case highlights the complementary value of imprint cytology and an appropriate immunohistochemical panel, in addition to frozen sections, in avoiding misclassification of tNENs as type A thymoma.
- 26 January 2026
- p. 25039
Angioimmunoblastic T-cell lymphoma with lymphomatous effusion: Diagnostic challenges and cytology-based approaches.
Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive peripheral T-cell lymphoma with a poor prognosis. Lymphomatous serous effusion, defined as the presence of malignant lymphoma cells in the pleural, pericardial, or peritoneal fluid, is a rare but clinically important manifestation, particularly when a lymph node biopsy is difficult or delayed. We performed a narrative review of case reports and a small series of AITL cases with lymphomatous effusion, focusing on the clinical presentation, cytologic features, ancillary studies, and outcomes. Reported patients are typically older adults with advanced-stage disease; effusions are usually exudative, of low volume, and cytologically tumor-cell-poor but inflammation-rich; therefore, atypical T follicular helper (TFH)-type T cells are easily overlooked or misclassified. Immunocytochemistry (ICC) on cell block or cell-transfer preparations, flow cytometry, and EBER in situ hybridization improve the recognition of the AITL phenotype, whereas next-generation sequencing (NGS) can detect hallmark mutations such as RHOA G17V, TET2, DNMT3A, and IDH2 directly from effusion samples, enabling a less invasive diagnostic approach when tissue is not readily available. According to previous reports, lymphomatous effusion, which is frequently measured in months, is associated with a short survival. Based on these data and current World Health Organization (WHO) and National Comprehensive Cancer Network (NCCN) guidance, we propose a practical fluid-based diagnostic algorithm that integrates cytology, ancillary tools, and lymph node biopsy when feasible, and we highlight the need for standardized effusion-based workflows, multicenter registries, and the integration of liquid biopsies, multiomics, and artificial intelligence-assisted cytology to refine risk stratification and guide therapy in this distinct subgroup.
- 26 January 2026
- p. 25039
Angioimmunoblastic T-cell lymphoma with lymphomatous effusion: Diagnostic challenges and cytology-based approaches.
Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive peripheral T-cell lymphoma with a poor prognosis. Lymphomatous serous effusion, defined as the presence of malignant lymphoma cells in the pleural, pericardial, or peritoneal fluid, is a rare but clinically important manifestation, particularly when a lymph node biopsy is difficult or delayed. We performed a narrative review of case reports and a small series of AITL cases with lymphomatous effusion, focusing on the clinical presentation, cytologic features, ancillary studies, and outcomes. Reported patients are typically older adults with advanced-stage disease; effusions are usually exudative, of low volume, and cytologically tumor-cell-poor but inflammation-rich; therefore, atypical T follicular helper (TFH)-type T cells are easily overlooked or misclassified. Immunocytochemistry (ICC) on cell block or cell-transfer preparations, flow cytometry, and EBER in situ hybridization improve the recognition of the AITL phenotype, whereas next-generation sequencing (NGS) can detect hallmark mutations such as RHOA G17V, TET2, DNMT3A, and IDH2 directly from effusion samples, enabling a less invasive diagnostic approach when tissue is not readily available. According to previous reports, lymphomatous effusion, which is frequently measured in months, is associated with a short survival. Based on these data and current World Health Organization (WHO) and National Comprehensive Cancer Network (NCCN) guidance, we propose a practical fluid-based diagnostic algorithm that integrates cytology, ancillary tools, and lymph node biopsy when feasible, and we highlight the need for standardized effusion-based workflows, multicenter registries, and the integration of liquid biopsies, multiomics, and artificial intelligence-assisted cytology to refine risk stratification and guide therapy in this distinct subgroup.
- Open Access
- 15 December 2025
- Published by Wiley in Precision Medical Sciences
- Vol. 15 (1) , 29-34
A case of ROS1 ‐rearranged lung adenocarcinoma in a young man with multiple serosal effusions: Diagnostic pitfalls in pericardial fluid cytology
ROS1 ‐rearranged lung adenocarcinoma is a rare subset of non‐small‐cell lung cancer, typically occurring in young never‐smokers. Its occurrence in very young men with a fluid‐dominant presentation is unusual and may lead to diagnostic pitfalls. We herein report a case of ROS1 ‐rearranged lung adenocarcinoma in a never‐smoking man in his early 20s who presented with pericardial, pleural, and peritoneal effusion. The initial cytological assessment of the pericardial fluid, interpreted in the context of the patient's very young age, favored reactive mesothelial proliferation. Clusters with nuclear eccentricity and prominent nucleoli prompted the preparation of a cell block. Hematoxylin and eosin staining revealed cohesive nests, cords of tumor cells, and true gland‐forming tubular structures with scattered mucin‐containing cells. Immunohistochemistry confirmed primary lung adenocarcinoma, and a molecular analysis identified a ROS1 rearrangement. This case underscores the rarity of ROS1 ‐rearranged adenocarcinoma in a very young never‐smoking man, its atypical fluid‐dominant manifestation, particularly pericardial effusion, and the importance of a systematic diagnostic approach that incorporates smear cytology, cell block, immunohistochemistry, and molecular testing, supported by multidisciplinary discussion to avoid a misdiagnosis and guide targeted therapy.
- 15 December 2025
- Published by Wiley in Precision Medical Sciences
- Vol. 15 (1) , 29-34
Open AccessA case of ROS1 ‐rearranged lung adenocarcinoma in a young man with multiple serosal effusions: Diagnostic pitfalls in pericardial fluid cytology
ROS1 ‐rearranged lung adenocarcinoma is a rare subset of non‐small‐cell lung cancer, typically occurring in young never‐smokers. Its occurrence in very young men with a fluid‐dominant presentation is unusual and may lead to diagnostic pitfalls. We herein report a case of ROS1 ‐rearranged lung adenocarcinoma in a never‐smoking man in his early 20s who presented with pericardial, pleural, and peritoneal effusion. The initial cytological assessment of the pericardial fluid, interpreted in the context of the patient's very young age, favored reactive mesothelial proliferation. Clusters with nuclear eccentricity and prominent nucleoli prompted the preparation of a cell block. Hematoxylin and eosin staining revealed cohesive nests, cords of tumor cells, and true gland‐forming tubular structures with scattered mucin‐containing cells. Immunohistochemistry confirmed primary lung adenocarcinoma, and a molecular analysis identified a ROS1 rearrangement. This case underscores the rarity of ROS1 ‐rearranged adenocarcinoma in a very young never‐smoking man, its atypical fluid‐dominant manifestation, particularly pericardial effusion, and the importance of a systematic diagnostic approach that incorporates smear cytology, cell block, immunohistochemistry, and molecular testing, supported by multidisciplinary discussion to avoid a misdiagnosis and guide targeted therapy.
- Open Access
- 13 August 2025
- Published by Springer Nature in Cureus
- Vol. 17 (8) , e89994
Sclerosing Angiomatoid Nodular Transformation of the Spleen: A Case Report Highlighting Diagnostic Challenges and the Role of Immunohistochemistry
Sclerosing angiomatoid nodular transformation (SANT) of the spleen is a rare, benign vascular lesion that poses significant diagnostic challenges owing to its nonspecific clinical and radiological features. We herein report the case of a 35-year-old male who presented with chronic left hypochondrial pain and was found to have a splenic mass with poor enhancement on computed tomography (CT) and an increased fluorodeoxyglucose uptake on positron emission tomography-CT. Total splenectomy was performed, and a histopathological examination revealed well-demarcated angiomatoid nodules with varying vascular channels, fibrosclerosis, and hemosiderin deposition. Immunohistochemistry revealed a characteristic tri-phenotypic vascular profile of CD34+/CD31+/CD8− capillaries, CD8+/CD31+/CD34− sinusoid-like vessels, and CD31+ venules. Additional investigations ruled out associations between Epstein-Barr virus (EBV) and IgG4-related diseases. This case underscores the critical role of histopathology and immunohistochemistry in accurately diagnosing SANT and differentiating it from other splenic vascular tumors. We also emphasize the importance of considering SANT in the differential diagnosis of splenic masses, even in younger patients presenting with persistent unexplained abdominal pain.
- 13 August 2025
- Published by Springer Nature in Cureus
- Vol. 17 (8) , e89994
Open AccessSclerosing Angiomatoid Nodular Transformation of the Spleen: A Case Report Highlighting Diagnostic Challenges and the Role of Immunohistochemistry
Sclerosing angiomatoid nodular transformation (SANT) of the spleen is a rare, benign vascular lesion that poses significant diagnostic challenges owing to its nonspecific clinical and radiological features. We herein report the case of a 35-year-old male who presented with chronic left hypochondrial pain and was found to have a splenic mass with poor enhancement on computed tomography (CT) and an increased fluorodeoxyglucose uptake on positron emission tomography-CT. Total splenectomy was performed, and a histopathological examination revealed well-demarcated angiomatoid nodules with varying vascular channels, fibrosclerosis, and hemosiderin deposition. Immunohistochemistry revealed a characteristic tri-phenotypic vascular profile of CD34+/CD31+/CD8− capillaries, CD8+/CD31+/CD34− sinusoid-like vessels, and CD31+ venules. Additional investigations ruled out associations between Epstein-Barr virus (EBV) and IgG4-related diseases. This case underscores the critical role of histopathology and immunohistochemistry in accurately diagnosing SANT and differentiating it from other splenic vascular tumors. We also emphasize the importance of considering SANT in the differential diagnosis of splenic masses, even in younger patients presenting with persistent unexplained abdominal pain.